Cargando…
Experience (Mostly Negative) with the Use of Sympathomimetic Agents for Weight Loss
Sympathomimetic agents have a poor history of long-term success in the treatment of obesity. From earlier experiences with amphetamine and its analogs, to more recent drugs with direct effects on adrenergic receptors or indirect effects from release of catecholamines or inhibition of reuptake, cardi...
Autor principal: | Inchiosa, Mario A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931409/ https://www.ncbi.nlm.nih.gov/pubmed/20847890 http://dx.doi.org/10.1155/2011/764584 |
Ejemplares similares
-
Natural Sympathomimetic Drugs: From Pharmacology to Toxicology
por: Costa, Vera Marisa, et al.
Publicado: (2022) -
Procalcitonin elevation induced by sympathomimetic drug overdose
por: Kodama, Sota, et al.
Publicado: (2021) -
Resveratrol enhances the inotropic effect but inhibits the proarrhythmic effect of sympathomimetic agents in rat myocardium
por: Hernandez-Cascales, Jesús
Publicado: (2017) -
Sympathomimetic Effects of Acute E‐Cigarette Use: Role of Nicotine and Non‐Nicotine Constituents
por: Moheimani, Roya S., et al.
Publicado: (2017) -
Comparison of esmolol and labetalol, in low doses, for attenuation of sympathomimetic response to laryngoscopy and intubation
por: Singh, Sarvesh P., et al.
Publicado: (2010)